ACS MED CHEM LETT 润色咨询

ACS Medicinal Chemistry Letters

出版年份:2010 年文章数:2290 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1200926, encodeId=46f9120092632, content=该杂志接受综述性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f256543602, createdName=ms8000001964284284, createdTime=Wed Mar 09 16:16:29 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103531, encodeId=eebe1103531b7, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103532, encodeId=985311035324a, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571443, encodeId=0c5f5e144322, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:刚中1篇,一直很看好ACS的杂志。审稿速度很快初审2-3周,返修意见中肯,返修1周,效率高。期刊要求文章新颖性较高、生物活性好、对化合物合成技术和化合物数量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622508149, createdName=tianweicpu_87326411, createdTime=Fri May 24 23:22:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]
    2022-03-09 ms8000001964284284

    该杂志接受综述性文章吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200926, encodeId=46f9120092632, content=该杂志接受综述性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f256543602, createdName=ms8000001964284284, createdTime=Wed Mar 09 16:16:29 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103531, encodeId=eebe1103531b7, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103532, encodeId=985311035324a, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571443, encodeId=0c5f5e144322, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:刚中1篇,一直很看好ACS的杂志。审稿速度很快初审2-3周,返修意见中肯,返修1周,效率高。期刊要求文章新颖性较高、生物活性好、对化合物合成技术和化合物数量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622508149, createdName=tianweicpu_87326411, createdTime=Fri May 24 23:22:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    评审和期刊编辑一般会询问什么问题?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1200926, encodeId=46f9120092632, content=该杂志接受综述性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f256543602, createdName=ms8000001964284284, createdTime=Wed Mar 09 16:16:29 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103531, encodeId=eebe1103531b7, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103532, encodeId=985311035324a, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571443, encodeId=0c5f5e144322, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:刚中1篇,一直很看好ACS的杂志。审稿速度很快初审2-3周,返修意见中肯,返修1周,效率高。期刊要求文章新颖性较高、生物活性好、对化合物合成技术和化合物数量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622508149, createdName=tianweicpu_87326411, createdTime=Fri May 24 23:22:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]
    2021-12-28 Mia

    评审和期刊编辑要求我补实验,就一定要补么,不补行不行?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1200926, encodeId=46f9120092632, content=该杂志接受综述性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f256543602, createdName=ms8000001964284284, createdTime=Wed Mar 09 16:16:29 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103531, encodeId=eebe1103531b7, content=评审和期刊编辑一般会询问什么问题?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103532, encodeId=985311035324a, content=评审和期刊编辑要求我补实验,就一定要补么,不补行不行?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571443, encodeId=0c5f5e144322, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:刚中1篇,一直很看好ACS的杂志。审稿速度很快初审2-3周,返修意见中肯,返修1周,效率高。期刊要求文章新颖性较高、生物活性好、对化合物合成技术和化合物数量要求不高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff622508149, createdName=tianweicpu_87326411, createdTime=Fri May 24 23:22:00 CST 2019, time=2019-05-24, status=1, ipAttribution=)]
    2019-05-24 tianweicpu_87326411

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:刚中1篇,一直很看好ACS的杂志。审稿速度很快初审2-3周,返修意见中肯,返修1周,效率高。期刊要求文章新颖性较高、生物活性好、对化合物合成技术和化合物数量要求不高。

    0

共6条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分